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Summary
Objective: Bone morphogenetic protein-2 (BMP-2)-mediated stimulation of articular cartilage proteoglycan (PG) synthesis is suppressed in
arthritic murine knee joints and by interleukin-1 (IL-1). The goal of this study was to investigate whether the gaseous mediator nitric oxide
(NO) plays a crucial role in the inhibition of BMP-2 effects by IL-1.
Methods: Bone morphogenetic protein-2 alone or in combination with IL-1 was injected into the right knee joint of wild-type and NOS2
deficient C57Bl/6×129/Sv mice. Proteoglycan synthesis was measured ex vivo by incorporation of 35S-sulfate on day 1, 2 and 3 after
injection. To study the role of NO in the inhibition BMP-2-mediated stimulation of PG synthesis in arthritic joints, BMP-2 was injected
intra-articularly in the joints of wild-type and NOS2 deficient mice with zymosan-induced arthritis. To check for NOS2 deficiency, NO
production was measured in conditioned medium after challenge of patellae with surrounding tissue with IL-1.
Results: BMP-2 potently stimulated proteoglycan synthesis in articular cartilage of normal knees (up to 4-fold) but not in arthritic knees.
Co-injection of BMP-2 with tumor necrosis factor  had no effect on BMP-2-mediated stimulation of PG synthesis but co-injection with IL-1
 resulted in a nearly total inhibition of BMP-2-mediated stimulation. In contrast, in NOS2 deficient mice IL-1 had no effect on
BMP-2-mediated stimulation of PG synthesis. However, injection of BMP-2 into arthritic knee joints of NOS2 knock out mice did not result
in significant stimulation of PG synthesis.
Conclusions: In this study we show that NO plays a role in the inhibition of BMP-2-mediated stimulation of PG synthesis by IL-1. However,
NO, or at least NOS2, plays no dominant role in the inhibition of BMP-2 effects in arthritic knee joints. © 2000 OsteoArthritis Research
Society International
Key words: Bone Morphogenetic Protein-2, Nitric Oxide, Interleukin-1, Articular cartilage.Received 3 April 1999; accepted 1 September 1999.
Corresponding author and offprint requests: P. M. van der Kraan,
Ph. D., Department of Rheumatology, University Hospital
Nijmegen, Geert Grooteplein 8, 6525 GA Nijmegen, The
Netherlands. E-mail: P.vanderkraan@reuma.azn.nl. Tel: 31-24-
3616568, Fax: 31-24-540403.
P. M. van der Kraan is supported by ‘Het national Reumafonds’
(Dutch League against Rheumatism).Introduction
A major consequence of rheumatoid arthritis and osteo-
arthritis is degradation of articular cartilage of which proteo-
glycan (PG) depletion is a crucial aspect. This process
results in severe impairment of the function of the affected
joints. Factors that are able to increase the synthesis of
PGs and stimulate the replenishment of PGs in the dis-
eased cartilage could be of therapeutic value. Possible
candidates to fulfil this role are the bone morphogenetic
proteins (BMPs) of which BMP-2 is a representative known
to stimulate cartilage PG synthesis in vitro1 and, as shown
by our group earlier, in vivo.2,3
The BMPs belong to the TGF  superfamily. This super-
family of dimeric molecules consist of at least 30 members
of which the BMPs are the largest subgroup. All members
signal by serine/threonine kinases.4 BMP-2 appears to
participate both in chondrogenesis as well as in the main-82tenance of the chondrocyte phenotype. BMP-2 was shown
to be involved in the differentiation of embryonic mesen-
chymal skeletal progenitor cells to chondrocytes5,6 and
was also able to induce the transdifferentiation of adult
fibroblast to chondrocytes.7 In the articular cartilage of
young calves BMP-2 stimulated proteoglycan synthesis as
measured by 35S-sulfate incorporation and by expression
of aggrecan mRNA.1 Moreover, in young adult C57Bl/6
mice a single intra-articular injection of BMP-2 resulted in
potent stimulation of proteoglycan synthesis in articular
cartilage of the knee joint.3,4
In contrast to the anabolic factor BMP-2, IL-1 appears to
be an important catabolic factor which has been shown to
be a crucial mediator of cartilage destruction in exper-
imental models of arthritis.8,9 Furthermore it has been
recently shown in patients with rheumatoid arthritis that
blocking of interleukin-1 with IL-1 receptor antagonist has a
beneficial effect on the progress of joint destruction in these
patients.10 At least part of the effect of interleukin-1 on
articular cartilage is mediated by the gaseous mediator
nitric oxide (NO).
Nitric oxide is a short-lived free radical which is synthe-
sized by three distinct NO synthases (NOS), neural NOS
(NOS1), inducible NOS (NOS2) and endothelial NOS
(NOS3).11 Nitric oxide produced by NOS2 appears to be
involved in the inhibition of articular cartilage proteoglycan
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ANIMALS
The animals used in this study, the NOS2 −/− knock out
mice with a C57Bl/6×129/Sv background and the wild-type
C57Bl/6×129/Sv, were bred in our specific pathogen-free
animal housing facilities. The animals were kept in cages
with a wood chip bedding and had unlimited access to a
standard diet and acidified tap water.EFFECT OF IL-1 AND TNF- ON NO SYNTHESIS AND CONTROL OF
NOS2 DEFICIENCY
Patellae with a standard amount of surrounding tissue
were dissected from the knee joints of NOS2 −/− and
wild-type mice as described before.16 Patellae from knock-
out and wild-type mice were cultured for 24 hours in culture
medium (one patella/200 l medium) in the presence of
10 ng/ml IL-1, 10 ng/ml TNF  or medium alone. The
conditioned medium was checked for NO production by
measuring nitrite (NO−2 ), a stable end product of NO, using
the Griess reaction. In brief, 100 l conditioned medium
was mixed with 100 l Griess reagent (0.1% naphtylethyl-
enediamine dihydrochloride (Sigma), 1:1 diluted with 1.0%
sulfanilamide (Sigma) in 5% H3PO4). The optical density
was measured using flat bottomed microtiter plates
(Costar, Cambridge, MA, U.S.A.) at 454 nm with an ELISA
reader. Standards of NaNO2 (Merck, Darmstadt, Germany)
were used as controls.INJECTION WITH RECOMBINANT CYTOKINES
Recombinant human BMP-2 (a gift of E. Morris, Genetics
Institute Inc. (Cambridge, MA, U.S.A.), recombinant murine
IL-1 (donated by Pfizer Central Research, Croton, CT,
U.S.A.), and TNF  (R & D Systems Ltd, Abingdon, U.K.)
were dissolved in saline +0.1% ultrapure bovine serum
albumine (Sigma, St Louis, MO, U.S.A.). Six microliter
volumes of BMP-2 or BMP-2 plus IL-1 were injected into
the joint cavity of the right knee joint. The left, control knee
joint received an equal volume of vehicle simultaneously.INDUCTION OF ARTHRITIS
Zymosan-induced arthritis (ZIA) was evoked by injection
of 180 g zymosan A (Saccharomyces Cerevisiae, 6 l) in
the right knee joint. Before injection zymosan was emulsi-
fied by boiling and sonification. The contralateral knee joint
was injected with an equal volume of saline. Cytokines
were injected on day three after induction of arthritis. In the
ZIA model, arthritis is fully established at this time point.13TREATMENT OF ARTHRITIC MICE WITH L-NAME
Starting at one day after the induction ZIA wild-type mice
were treated with the general NO synthase inhibitor N-nitro-
L-arginine methyl ester (L-NAME, Sigma). Mice were
injected intraperitoneally every day until the end of the
experiment with 50 mg/kg L-NAME. On day three after
induction of arthritis both L-NAME treated and control mice
were injected with BMP-2 in the right knee joint and
proteoglycan synthesis was measured 24 hours later.DETERMINATION OF PROTEOGLYCAN SYNTHESIS
Proteoglycan synthesis was measured ex vivo according
to the method of van den Berg et al.16 Patellae with a
standard amount of surrounding tissue were dissected from
the knee joints whereafter the patellae were labeled
for 2 hours with 35S-sulfate (Na235SO4, Dupont, NEN
products, Boston, MA, U.S.A.). Subsequently, patellae
were washed, fixated and decalcified. After decalcification
the patellar cartilage was stripped entirely from the under-
lying bone and dissolved in lumasolve (Lumac, Groningen,
The Netherlands). The 35S content of the cartilage of each
patellae separate was measured by liquid scintillation
counting.STATISTICS
Data are expressed as the mean±SD. Statistical signifi-
cance was tested using the student T-test in combination
with the Bonferroni procedure. A P<0.05 was considered
statistical significant.ResultsFig. 1. Stimulation of PG synthesis in patellar cartilage, as
measured by 35S-sulfate incorporation, in male C57Bl/6×129/Sv
mice effect by a single injection with 200 ng BMP-2. The 35S-
sulfate incorporation is expressed as a percentage of the vehicle-
injected left knee joint. Each value represents the mean±SD of six
animals.EFFECT OF BMP-2 ON PG SYNTHESIS IN NORMAL AND ARTHRITIC
KNEE JOINTS
In accordance with earlier studies using C57Bl/6 mice
BMP-2 strongly stimulated PG synthesis in the knee joints
of normal C57Bl/6×129/Sv mice (Fig. 1). Injection of
200 ng BMP-2 significantly increased PG synthesis onsynthesis by IL-1.12,13 However, the role of NO in proteo-
glycan breakdown is less clear. Nitric oxide has been
shown to activate metalloproteinases and the NOS inhibitor
L-NMA induced increased instead of reduced proteoglycan
degradation in bovine explants.14,15
In earlier studies using C57Bl/6 mice, BMP-2 appeared
to be a potent stimulator of PG synthesis in normal joints
but not in arthritic joints or in combination with IL-1. The
goal of this study was to investigate whether NO plays both
a crucial role in the inhibition BMP-2-mediated stimulation
of PG synthesis by IL-1 and in arthritic knee joints.
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articular cartilage.Fig. 2. Absence of BMP-2 effects on PG synthesis in arthritic
C57Bl/6×129/Sv mice. BMP-2 was injected in the right knee joints
of control mice and in joints of mice with zymosan arthritis. BMP-2
was injected 3 days after the induction of zymosan-induced
arthritis. The values are expressed as percentage of the left
non-injected controls and each value represents the mean (SD)
(N=6). Shown is one representative experiment out of three. The
35S-sulfate incorporation in the arthritic, non-BMP-2-injected knees
was 40% of the incorporation in the left knees of the normal mice.
(Control closed bars, BMP-2 open bars.)Fig. 3. Inhibition of BMP-2-mediated stimulation of PG synthesis by
IL-1 and TNF  in wild type and NOS2−/− mice. BMP-2 (200 ng)
was injected alone or in the presence of cytokine in the right knee
joint of wild-type or NOS2−/− mice. In wild-type mice co-injection
of BMP-2 with IL-1 resulted in a nearly complete inhibition of the
stimulation of PG synthesis by BMP-2 on day 1, 2 and 3 after
injection of the cytokines (3A). However, in mice deficient in NOS2,
IL-1 had no significant effect on the stimulation of PG synthesis by
BMP-2 (3B). On all time points BMP-2 significantly stimulated PG
synthesis. Expressed are the means (SD) of at least six mice per
group of a representative experiment out of three. The 35S-sulfate
incorporation values are a percentage of the values in the vehicle-
injected left knee joints. (Control closed bars, BMP-2 open bars,
BMP-2/IL-1 striped bars, TNF  10 ng/BMP-2 bars with squares,
TNF  100 ng/BMP-2 hatched bars.)EFFECT OF BMP-2 IN ARTHRITIC KNEE JOINTS OF NOS2−/− AND
L-NAME TREATED MICE
BMP-2 stimulated the PG synthesis in murine knee joints
of NOS2−/− mice in the presence of IL-1. Therefore we
investigated whether BMP-2 also retained its stimulating
activity on PG synthesis in arthritic knee joints of NOS2−/−
mice. Although NOS2 deficiency protects from the inhibition
of BMP-2 stimulation of PG synthesis by IL-1, in arthritic
joints of NOS2−/− mice BMP-2 still lacked significant
stimulating effects on PG synthesis (Fig. 4). In addition,day 1 and resulted in a maximal stimulation of nearly
threefold on day 2. Thereafter PG synthesis decreased and
was comparable to controls on day 5. However, in arthritic
knee joints, a similar BMP-2 dose (200 ng) was unable to
stimulate PG synthesis in articular cartilage (Fig. 2). On day
2 after BMP-2 injection PG synthesis in normal knee joints
was approximately 270% while in arthritic knee joints
BMP-2 injection did not result in a significant stimulation of
PG synthesis.EFFECT OF IL-1 ON PG SYNTHESIS IN KNEE JOINTS OF NORMAL
AND NOS2−/− MICE
To investigate whether the absence of stimulation of PG
synthesis by BMP-2 in the inflamed joints could be caused
by the presence of pro-inflammatory cytokines in these
joints, BMP-2 (200 ng) was co-injected with IL-1 (10 ng)
and TNF  (10, 100 ng) in normal murine knee joints
(NOS2 controls). On day 1, 2 and 3 after the intra-articular
injections PG synthesis was measuered ex vivo in patellar
cartilage by 35S-sulfate incorporation. Injection of BMP-2
together with IL-1 resulted in almost complete inhibition of
stimulation of PG synthesis by BMP-2 (Fig. 3A). While on
day 1, 2 and 3 BMP-2 alone significantly stimulated PG
synthesis, co-injections of BMP-2 with IL-1 did not lead to
increased PG synthesis. Co-injection of BMP-2 with TNF 
had no significant effect on the BMP-2-mediated stimu-
lation of PG synthesis (Fig. 3A). Co-injection of 10 or
100 ng TNF  with BMP-2 did not result in a diminished
incorporation of 35S-sulfate compared to injection of BMP-2
alone. TNF  had no stimulatory effect on NO production
during incubation of patellae in vitro (Table 1).
As it has been shown that at least part of the IL-1 effects
on articular cartilage are mediated by NO, the experiment
described above was repeated with NOS2 knock out mice.
The NOS2−/− mice had no elevated production of NO after
in-vitro incubation of patella with IL-1 in contrast to control
mice (Table 1). As can been seen in Fig. 3B, in NOS2−/−
mice the combination of BMP-2 and IL-1 stimulated the PG
synthesis in articular cartilage as potent as BMP-2 alone.
This indicates that NO plays an important role in the
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tor of NO synthesis, did not show an increased synthesis of
PG after intra-articular injection of BMP-2 in the inflamed
joints. Injection of BMP-2 (200 ng) in the arthritic joints of
L-NAME treated mice resulted in an increase in PG syn-
thesis of 6±5% while in the control joints of L-NAME
treated mice an 76±15% increase in PG synthesis was
observed one day after injection of BMP-2.Discussion
In this study we show that NO plays an important role
in the inhibition of BMP-2-mediated stimulation by IL-1.
Co-injection of BMP-2 with IL-1 blocked the effects of
BMP-2 on PG synthesis in articular cartilage in wild-type
mice but not in NOS2 knock out mice. Remarkably, NO
plays no significant role in the inhibition of BMP-2 effects in
arthritic joints.
The absence of BMP-2 effects on PG synthesis in
arthritic joints appears to be comparable with the phenom-
enon of IGF non-responsiveness which has been observed
in arthritic joints earlier. Patellar cartilage from murine
arthritic knee joints is insensitive for stimulation of PG
synthesis by IGF-I, this in contrast to cartilage from normal
knee joints.17 However, in contrast to the effects of IL-1 on
BMP-2, IL-1 alone is not sufficient to induce IGF non-
responsiveness in articular cartilage.18 Moreover, cartilage
from arthritic joints of NOS2−/− mice remained responsive
to IGF-I in vitro13 while arthritic knee joints from NOS2−/−
mice were non-responsive to BMP-2 as shown in this study.
These observations indicate that although BMP-2 andIGF-I non-responsiveness have some aspects in common
the overall mechanism is most likely different.
The mechanism of inhibition of BMP-2 response by IL-1
and NO can be multiple. Down-regulation or inactivation of
BMP receptors on the cell membrane by NO or NO
products is a possibility. An alternative explanation is that
IL-1/NO reduce the availability of the intracellular second
mediators involved in BMP signaling (SMAD 1 and 5) or
up-regulate the inhibitory SMADs and in this way block
the effects of BMP-2 on PG synthesis. An overall non-
responsiveness of the chondrocytes to anabolic factors
appears to be unlikely since PG synthesis of chondrocytes
from arthritic knee joints or after injection of IL-1 can still be
stimulated by TGF .2,19 The latter observation also implies
that down-regulation of SMAD 4, involved in both BMP and
TGF  signaling, can not be involved in the inhibition of
BMP-2-mediated stimulation of PG synthesis.
Our results show that although NO (NOS2) plays a
crucial role in mediating the effects of IL-1 on the inhibition
of BMP-2 stimulated PG synthesis, in arthritic joints NOS2
deficiency is not sufficient to restore the response of the
chondrocytes to BMP-2. Moreover, treatment of arthritic
mice with L-NAME also did not result in maintenance of the
response to BMP-2 in the arthritic knee joints. These
results indicate that in arthritic joints other factors than NO
appear to be involved in the inhibition of BMP-2. Factors in
arthritic knee joints, such as IL-17 and leukemia inhibitory
factor (LIF), can play a role in inhibition of BMP-2 effects.
However, a mediator suggested to be involved in articular
cartilage pathology, TNF ,20 had no significant effects on
BMP-2-mediated stimulation of PG synthesis but TNF 
had also no stimulatory effect on NO production in vitro in
the dose tested.
The effects of the arthritis process in general and of IL-1
and NO in particular on BMP-2 signaling can have substan-
tial consequences for articular cartilage homeostasis and
repair. Under the conditions of accelerated or even normal
catabolic processes in articular cartilage the inhibition of
anabolic factors will eventually result in breakdown of the
cartilage matrix. Repair of damaged articular cartilage will
be seriously impaired by inflammatory mediators in the
arthritic joint due to the inhibition of growth factors such as
BMP-2 which can potentially play an important role in the
repair process. Moreover, since it has been shown that NO
is significantly produced in joints of patients with osteo-
arthritis, one could speculate that repair of articular carti-
lage is not only impaired in joints of arthritis patients but
also in joints of patients with degenerative joint diseases.21
In conclusion, our data show that stimulation of PG
synthesis by BMP-2 is strongly impaired in arthritic knee
joints. Although this process can be mimicked with IL-1 and
it appears that NO plays a role in IL-1-induced inhibition of
BMP-2 in arthritic knee joints, deficiency of NOS2 does not
lead to restoration of the BMP-2-mediated stimulation
under arthritic conditions. The inhibition of anabolic
factors by the arthritic process can have severe effects on
homeostasis and repair of articular cartilage.Acknowledgments
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Effect of IL-1 (10 ng/ml), TNF  (10 ng/ml) and medium alone on
the production of NO (M) by patellae from NOS2−/− and wild-
type mice during a 24 hours culture period. The conditioned
medium was checked for NO by measuring nitrite. Expressed are






C57Bl/6×129/Sv+/+ 25.6 (4.9 M) 7.8 (4.8 M) 7.3 (3.4 M)
NOS2−/− 4.2 (1.4 M) 3.4 (1.2 M) 3.8 (1.8 M)Fig. 4. Effect of BMP-2 in arthritic knee joints of wild-type and
NOS2−/− mice. Although BMP-2 strongly stimulated PG synthesis
in non-arthritic wild-type mice no stimulation was observed in
arthritic wild-type or in arthritic NOS2−/− mice. Expressed are the
means (SD) of at least six mice per group of an representative
experiment out of three. The 35S-sulfate incorporation values are a
percentage of the values in the vehicle-injected left knee joints.
(Control striped bars, BMP-2 dotted bars.)References
1. Sailor LZ, Hewick RM, Morris EA. Recombinant human
bone morphogenetic protein-2 maintains the articular
86 P. M. van der Kraan et al.: BMP-2-mediated stimulation of proteoglycan synthesischondrocyte phenotype in long-term culture. J Bone
Joint Surg 1996;14:937–45.
2. Glansbeek HL, van Beuningen HM, Vitters EL, Morris
EA, van der Kraan PM, van den Berg WB. Bone
morphogenetic protein 2 stimulates articular cartilage
proteoglycan synthesis in vivo but does not counter-
act interleukin-1 effects on proteoglycan synthesis
and content. Arthritis Rheum 1997;40:1020–8.
3. Van Beuningen HM, Glansbeek HL, van der Kraan PM,
van den Berg WB. Differential effects of local appli-
cation of BMP-2 or TGF-1 on both articular cartilage
composition and osteophyte formation. Osteoarthritis
Cart 1998;6:306–17.
4. Lin HY, Moustakis A. TGF  receptors: structure and
function. Cell Mol Biol 1996;40:337–49.
5. Rosen V, Nove J, Song JJ, Thies S, Cox K, Wozney
JM. Resposiveness of clonal limb bud cell lines to
bone morphogenetic protein 2 reveals a sequential
relationship between cartilage and bone cell pheno-
types. J Bone Joint Surg 1994;9:1759–68.
6. Roark EF, Greer K. Transforming growth factor- and
bone morphogenetic protein-2 act by distinct mech-
anisms to promote chick limb cartilage differentiation
in vitro. Developm Dyn 1994;200:103–16.
7. Hoshi K, Amizuki N, Sakou T, Kurokawa T, Ozawa H.
Fibroblasts of spinal ligaments pathologically differ-
entiate into chondrocytes induced by recombinant
human bone morphogegenetic protein-2: Morpho-
logical examinations for ossification of spinal
ligaments. Bone 1997;21:155–62.
8. Van de Loo FAJ, Arntz OJ, Otterness IG, Van den Berg
WB. Protection against cartilage proteoglycan syn-
thesis inhibition by antiinterleukin 1 antibodies in
experimental arthritis. J Rheumatol 1992;19:348–56.
9. Van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz
OJ, van den Berg WB. Role of interleukin-1, tumor
necrosis factor , and interleukin-6 in cartilage
proteoglycan metabolism and destruction: effect of in
situ blocking in murine antigen- and zymosan-
induced arthritis. Arthritis Rheum 1995;38:164–72.
10. Bresnihan B, Alvaro-Gracia J, Cobby M, Doherty M,
Domljan Z, Emery P, et al. Treatment of rheumatoid
arthritis with recombinant human interleukin 1 recep-
tor antagonist. Arthritis Rheum 1998;41:2196–204.
11. Clancy RM, Abramson SB. Nitric oxide: A novel
mediator of inflammation. Proc Soc Exp Biol Med
1995;210:93–101.12. Van de Loo FAJ, Arntz OJ, van den Berg WB. Effect of
interleukin 1 and leukemia inhibitory factor on
chondrocyte metabolism in articular cartilage from
normal and interleukin-6-deficient mice: role of nitric
oxide and Il-6 in the suppression of proteoglycan
synthesis. Cytokine 1997;9:453–62.
13. Van de Loo FAJ, Arntz OJ, van Enckevort FHJ, van
Lent PLEM, van den Berg WB. Reduced cartilage
proteoglycan loss during zymosan-induced gonarthri-
tis in NOS2-deficient mice and in anti-interleukin-1-
treated wild-type mice with unabated joint
inflammation. Arthritis Rheum 1998;41:634–46.
14. Hanglow Ac, Rowan K, Lusch L, Coffey JW. Degra-
dation of bovine cartilage proteoglycan in vitro is
enhanced by inhibition of nitric oxide synthase.
Inflamm Res 1995;44:S151–2.
15. Stafanovic-Racic M, Morales TI, Taskiran D, McIntyre
LA, Evans CH. The role of nitric oxide in proteo-
glycan turn-over by bovine cartilage organ cultures.
J Immunol 1996;156:1213–20.
16. Van den Berg WB, Kruijsen MWM, van de Putte LBA.
The mouse patella assay: an easy method of
quantitating articular cartilage chondrocyte function
in vivo and vitro. Rheumatol Int 1982;1:165–9.
17. Schalkwijk J, Joosten LAB, van den Berg WB, van den
Putte LBA. Condrocyte nonresponsiveness to
insulin-like growth factor 1 in experimental arthritis.
Arthritis Rheum 1989;32:894–900.
18. Verschure PJ, Joosten LAB, van de Loo FAJ, van den
Berg WB. IL-1 has no direct role in the IGF-I non-
responsiveness state during experimentally induced
arthritis in mouse knee joints. Ann Rheum Dis
1995;54:976–82.
19. Glansbeek HL, van Beuningen HM, Vitters EL, van der
Kraan PM, van den Berg WB. Stimulation of articular
cartilage repair in established arthritis by local admin-
istration of transforming growth factor  into murine
knee joints. Lab Invest 1998;78:133–42.
20. Feldmann M, Brennan FM, Chantry D, Haworth C,
Turner M, Abney E, et al. Cytokine production in the
rheumatoid joint. Implications for treatment. Ann
Rheum Dis 1990;49:480–6.
21. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP,
Sturrock RD, et al. Production of nitric oxide in the
synovial membrane rheumatoid and osteoarthritis
patients. J Exp Med 1996;184:1519–24.
